VectivBio is based in Basel, Switzerland. It has raised $145M in total funding. Latest round: Growth. Backed by Forbion, Citadel, Cormorant Capital.
VectivBio is based in Basel, Switzerland. VectivBio has raised $145M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Growth announced in July 2022. The round record for VectivBio runs through 2022; nothing later has been disclosed. Investors on record include Forbion, Citadel, Cormorant Capital, Versant Ventures, OrbiMed. 5 distinct backers are named across the disclosed rounds.
Round data for VectivBio is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in Basel and backer lists below.
Company funding database · Investor directory · Founder database · Mega-rounds 2026